³ÉÈË´óƬ

Join us to hear from experts at the forefront of cancer research to delve into the key challenges faced by researchers and gain insights into the innovative approaches being taken to overcome these obstacles.

Be part of a thought-provoking discussion about the paradigm shift in cancer prognosis, from generalised predictions to individualised risk assessments based on genetic makeup. Experts will explore how this approach has transformed cancer research, and how this may impact on patient outcomes based on their unique characteristics and needs.

The speakers will address some key cancer conundrums faced by both the medical and general communities.

Broaden your perspective on the future of cancer diagnosis, treatment, and research whether you are an academic researcher, healthcare professional, or simply interested in understanding the latest developments in cancer research. Don’t miss your opportunity to be part of the conversation that could shape the future of cancer research and care.

Speakers

Dr Charles Mullighan (Deputy Director, Comprehensive Cancer Centre St Jude Children’s Research Hospital, Memphis)

Professor Jane Visvader (Joint Division Head, ACRF Cancer Biology and Stem Cells, Walter and Eliza Hall Institute of Medical Research, Melbourne)

Professor Christopher Sweeney (Director, SAiGENCI)

Facilitated by Professor Corinna Van Den Heuvel Head of School, School of Biomedicine, ³ÉÈË´óƬ